Cargando…

Identification of Antibiotic Administration as a Potentially Novel Factor Associated With Tacrolimus Trough Variability in Kidney Transplant Recipients: A Preliminary Study

Tacrolimus trough variability is an important risk factor for kidney allograft outcomes. Recent evidence suggests that the gut microbiota is associated with tacrolimus dosing requirements and direct metabolism of tacrolimus. We hypothesize that administration of antibiotics, which are known to alter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, YuanPu, Masand, Anjali, Wagner, Michael, Kapur, Sandip, Dadhania, Darshana, Lubetzky, Michelle, Lee, John Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739039/ https://www.ncbi.nlm.nih.gov/pubmed/31579813 http://dx.doi.org/10.1097/TXD.0000000000000930

Ejemplares similares

Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?
por: Haverals, Lien, et al.
Publicado: (2023)

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal
por: Pierce, Dana R., et al.
Publicado: (2021)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial
por: Webber, Allison B., et al.
Publicado: (2018)

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
por: Pernin, Vincent, et al.
Publicado: (2023)

Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation
por: Mo, Hyejin, et al.
Publicado: (2019)

Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms
por: de Graav, Gretchen N., et al.
Publicado: (2018)

High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients
por: Goodall, Dawn L., et al.
Publicado: (2017)

The Association of Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function
por: Mahaparn, Irisa, et al.
Publicado: (2023)

Efficacy of Prolonged-release Tacrolimus After Conversion From Immediate-release Tacrolimus in Kidney Transplantation: A Retrospective Analysis of Long-term Outcomes From the ADMIRAD Study
por: Kuypers, Dirk, et al.
Publicado: (2023)

Influence of Cold Ischemia Time in Kidney Transplants From Small Pediatric Donors
por: Kayler, Liise K., et al.
Publicado: (2017)

Impact of Cold Ischemia Time in Kidney Transplants From Donation After Circulatory Death Donors
por: Kayler, Liise, et al.
Publicado: (2017)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Association Between Peripheral Blood CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients
por: Nanmoku, Koji, et al.
Publicado: (2019)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Early Versus Late Conversion From Immediate to Prolonged-Release Tacrolimus After Renal Transplantation: Clinical Effects and Treatment Costs
por: Mendonça, Luís, et al.
Publicado: (2018)

Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration
por: Lakhani, Laila, et al.
Publicado: (2021)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study
por: Bottomley, Matthew J., et al.
Publicado: (2016)

Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts
por: Dooley, Bryan J., et al.
Publicado: (2020)

Atherosclerosis and Intrarenal Resistance Index in Kidney Transplant Recipients
por: Bloemendal, Niels T., et al.
Publicado: (2023)

En Bloc Cadaver Kidney Transplantation From a 9-Month-Old Donor to an Adult Recipient: Maturation of Glomerular Size and Podocyte in the Recipient
por: Hirukawa, Takashi, et al.
Publicado: (2017)

Safety and Efficacy of Reduced Prolonged-release Tacrolimus Exposure in De Novo Kidney Transplantation: A Randomized, Open-label, Pilot Study in Asia—OPTIMIZE Study
por: Kim, Young Hoon, et al.
Publicado: (2019)

The Influence of Donor to Recipient Size Matching on Kidney Transplant Outcomes
por: Arshad, Adam, et al.
Publicado: (2018)

The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients
por: Gagnon, Marie-France, et al.
Publicado: (2019)

Perspectives of Kidney Transplant Recipients on eHealth: Semistructured Interviews
por: Tang, James, et al.
Publicado: (2022)

Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients
por: Filiopoulos, Vassilis, et al.
Publicado: (2018)

Effect of Sodium Bicarbonate in Kidney Transplant Recipients With Chronic Metabolic Acidosis
por: Schulte, Kevin, et al.
Publicado: (2019)

Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Liver Enzymes and the Development of Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
por: Klaassen, Gerald, et al.
Publicado: (2017)

Differences in Gene Expression in Older Compared With Younger Kidney Transplant Recipients
por: Schaenman, Joanna M., et al.
Publicado: (2019)

Blood Pressure Treatment in Kidney Transplant Recipients—Can We Improve?
por: Onsøien, Mari O., et al.
Publicado: (2021)

The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
por: Langberg, Nina Elisabeth, et al.
Publicado: (2021)

An Unusual Cause of Hepatitis With Nephrotic Syndrome in a Kidney Transplant Recipient
por: Chan, Koon Ming, et al.
Publicado: (2022)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study
por: Wali, Ravinder K., et al.
Publicado: (2016)

Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants
por: Müller-Deile, Janina, et al.
Publicado: (2017)

Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
por: Burke, Michael Thomas, et al.
Publicado: (2017)

Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
por: Axelrod, David A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9t366hlejqa4b96peekcoi45v4